idarubicinol has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, M; Gieseler, F; Puschmann, M; Stiebeling, K; Valsamas, S | 1 |
1 other study(ies) available for idarubicinol and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Induction of apoptosis by idarubicin: how important is the plasma peak?
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Area Under Curve; Daunorubicin; DNA, Neoplasm; HL-60 Cells; Humans; Idarubicin; Leukemia, Promyelocytic, Acute | 2000 |